vs
太平洋生物科学（ASMB）与Laird Superfood, Inc.（LSF）财务数据对比。点击上方公司名可切换其他公司
Laird Superfood, Inc.的季度营收约是太平洋生物科学的1.2倍（$13.3M vs $10.8M），Laird Superfood, Inc.净利率更高（-13.2% vs -85.2%，领先72.1%），太平洋生物科学同比增速更快（57.6% vs 15.0%）
该公司是一家成立于2004年的美国生物科技企业，主要研发生产基因测序相关设备，同时也开展新型实时生物观测技术相关业务。目前拥有两大核心测序平台，分别是基于零模波导特性的单分子实时测序平台，以及结合天然核苷酸无痕连接技术的结合测序平台。
Laird Superfood是一家主营植物基功能性超级食品的企业，产品涵盖精品咖啡奶精、补水混合饮品、营养补充剂、植物能量零食等，面向健康意识较强的消费群体，主要在北美市场通过电商及线下零售渠道销售，主打可持续采购的清洁配方。
ASMB vs LSF — 直观对比
营收规模更大
LSF
是对方的1.2倍
$10.8M
营收增速更快
ASMB
高出42.6%
15.0%
净利率更高
LSF
高出72.1%
-85.2%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $10.8M | $13.3M |
| 净利润 | $-9.2M | $-1.8M |
| 毛利率 | — | 34.1% |
| 营业利润率 | -100.9% | -13.5% |
| 净利率 | -85.2% | -13.2% |
| 营收同比 | 57.6% | 15.0% |
| 净利润同比 | 4.3% | -341.4% |
| 每股收益（稀释后） | $-0.72 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASMBLSF
| Q4 25 | — | $13.3M | ||
| Q3 25 | $10.8M | $12.9M | ||
| Q2 25 | $9.6M | $12.0M | ||
| Q1 25 | $9.4M | $11.7M | ||
| Q4 24 | $7.4M | $11.6M | ||
| Q3 24 | $6.8M | $11.8M | ||
| Q2 24 | $8.5M | $10.0M | ||
| Q1 24 | $5.8M | $9.9M |
净利润ASMBLSF
| Q4 25 | — | $-1.8M | ||
| Q3 25 | $-9.2M | $-975.1K | ||
| Q2 25 | $-10.2M | $-362.2K | ||
| Q1 25 | $-8.8M | $-156.2K | ||
| Q4 24 | — | $-398.4K | ||
| Q3 24 | $-9.6M | $-166.1K | ||
| Q2 24 | $-11.2M | $-239.1K | ||
| Q1 24 | $-9.1M | $-1.0M |
毛利率ASMBLSF
| Q4 25 | — | 34.1% | ||
| Q3 25 | — | 36.5% | ||
| Q2 25 | — | 39.9% | ||
| Q1 25 | — | 41.9% | ||
| Q4 24 | — | 38.6% | ||
| Q3 24 | — | 43.0% | ||
| Q2 24 | — | 41.8% | ||
| Q1 24 | — | 40.0% |
营业利润率ASMBLSF
| Q4 25 | — | -13.5% | ||
| Q3 25 | -100.9% | -7.7% | ||
| Q2 25 | -115.2% | -3.3% | ||
| Q1 25 | -105.5% | -1.9% | ||
| Q4 24 | — | -4.1% | ||
| Q3 24 | -160.1% | -2.3% | ||
| Q2 24 | -143.0% | -3.4% | ||
| Q1 24 | -185.5% | -11.0% |
净利率ASMBLSF
| Q4 25 | — | -13.2% | ||
| Q3 25 | -85.2% | -7.6% | ||
| Q2 25 | -105.9% | -3.0% | ||
| Q1 25 | -93.6% | -1.3% | ||
| Q4 24 | — | -3.4% | ||
| Q3 24 | -140.4% | -1.4% | ||
| Q2 24 | -130.7% | -2.4% | ||
| Q1 24 | -156.9% | -10.3% |
每股收益（稀释后）ASMBLSF
| Q4 25 | — | — | ||
| Q3 25 | $-0.72 | — | ||
| Q2 25 | $-1.33 | — | ||
| Q1 25 | $-1.17 | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-1.51 | — | ||
| Q2 24 | $-1.98 | — | ||
| Q1 24 | $-1.66 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.5M | $5.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $182.7M | $11.5M |
| 总资产 | $240.0M | $19.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASMBLSF
| Q4 25 | — | $5.1M | ||
| Q3 25 | $22.5M | $5.1M | ||
| Q2 25 | $24.0M | $3.9M | ||
| Q1 25 | $23.4M | $7.0M | ||
| Q4 24 | $38.3M | $8.3M | ||
| Q3 24 | $28.5M | $7.9M | ||
| Q2 24 | $19.2M | $7.6M | ||
| Q1 24 | $18.7M | $7.1M |
股东权益ASMBLSF
| Q4 25 | — | $11.5M | ||
| Q3 25 | $182.7M | $12.8M | ||
| Q2 25 | $18.1M | $13.4M | ||
| Q1 25 | $27.1M | $13.3M | ||
| Q4 24 | $33.4M | $13.2M | ||
| Q3 24 | $26.0M | $13.1M | ||
| Q2 24 | $34.7M | $12.6M | ||
| Q1 24 | $32.6M | $12.7M |
总资产ASMBLSF
| Q4 25 | — | $19.2M | ||
| Q3 25 | $240.0M | $18.9M | ||
| Q2 25 | $80.8M | $20.4M | ||
| Q1 25 | $99.0M | $21.5M | ||
| Q4 24 | $119.2M | $19.3M | ||
| Q3 24 | $100.3M | $18.8M | ||
| Q2 24 | $115.3M | $18.0M | ||
| Q1 24 | $119.9M | $17.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.1M | $68.4K |
| 自由现金流经营现金流 - 资本支出 | $-15.2M | — |
| 自由现金流率自由现金流/营收 | -140.7% | — |
| 资本支出强度资本支出/营收 | 0.4% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASMBLSF
| Q4 25 | — | $68.4K | ||
| Q3 25 | $-15.1M | $1.2M | ||
| Q2 25 | $-16.8M | $-2.8M | ||
| Q1 25 | $-23.4M | $-1.3M | ||
| Q4 24 | $-51.1M | $339.2K | ||
| Q3 24 | $-15.2M | $305.8K | ||
| Q2 24 | $-17.1M | $642.7K | ||
| Q1 24 | $-18.4M | $-422.3K |
自由现金流ASMBLSF
| Q4 25 | — | — | ||
| Q3 25 | $-15.2M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-51.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-17.1M | — | ||
| Q1 24 | $-18.4M | — |
自由现金流率ASMBLSF
| Q4 25 | — | — | ||
| Q3 25 | -140.7% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -695.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -200.6% | — | ||
| Q1 24 | -317.7% | — |
资本支出强度ASMBLSF
| Q4 25 | — | — | ||
| Q3 25 | 0.4% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 0.2% | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASMB
暂无分部数据
LSF
| Wholesale | $7.0M | 52% |
| Coffee Tea And Hot Chocolate Products | $4.4M | 33% |
| Hydration And Beverage Enhancing Supplements | $1.6M | 12% |
| Other | $352.6K | 3% |
